Status:
UNKNOWN
Telemonitoring Among Patients With Multiple Myeloma
Lead Sponsor:
Isala
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A two-arm open-label parallel-group randomized controlled trial will be conducted to compare the telemonitoring (MM e-coach) with standard MM care. This study aimed to recruit 150 patients with recent...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- In order to be eligible to participate in this study, a participant (patient) must meet all of the -following criteria:
- signed informed consent
- \>18 years
- recently diagnosed MM patients with first-line or second-line treatment
- able to complete patient-reported outcome measures and experiences
- have minimal digital skills to check if they are able to interact with an e-coach
- can read and understand Dutch.
- Participants who meet any of the following criteria will be excluded from participation in this study
- psychiatric illness requiring secondary-care intervention
- too ill to engage with the intervention in the opinion of the clinical care team
- no perspective of \>12 months survival.
Exclusion
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05964270
Start Date
March 1 2021
End Date
July 1 2024
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isala Klinieken
Zwolle, Overijssel, Netherlands, 8012AB